If You Invested in DAMORA THERAPEUT (DMRA)
Looking for the live price? See the DMRA quote & overviewWhat $1,000 or $10,000 in DMRA Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Mar 10, 2026 |
|---|---|---|---|---|
| $1,000 | — | — | — | $1,118 +12% |
| $10,000 | — | — | — | $11,184 +12% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for DMRA$1,000 Investment Over Time
DMRA vs S&P 500Year-by-Year Returns
DMRA annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2026 | $25.51 | $28.53 | +11.8% | +11.8% |
About DAMORA THERAPEUT
Pharmaceutical Preparations · NASDAQ
Damora Therapeutics, Inc. develops biologic therapies for hematologic disorders, with a focus on mutant calreticulin-driven myeloproliferative neoplasms. The company’s programs address blood disorders including essential thrombocythemia and myelofibrosis, where its therapeutic work centers on disease-modifying biologics designed for patients with mutCALR-driven disease biology.
The company’s pipeline includes DMR-001 as its lead program, along with additional programs DMR-002 and DMR-003. These assets were added through the completed acquisition of privately held Damora Therapeutics in November 2025, which established the public company’s current development focus around mutCALR-targeted therapies for myeloproliferative neoplasms.
Damora operates as a biotechnology issuer rather than a diversified health-care products company. Its business model centers on research and development, regulatory preparation, and advancement of therapeutic candidates through the development pathway. Company communications describe a portfolio approach to biologics intended to cover the spectrum of patients with mutant calreticulin-driven myeloproliferative neoplasms.
Damora Therapeutics is incorporated in Delaware and lists its common stock on Nasdaq under the symbol DMRA. Regulatory records identify the company’s principal executive office in Waltham, Massachusetts. As a public biotechnology company, its recurring corporate disclosures include pipeline development, financial results, equity compensation, executive and board governance, auditor matters, and capital-structure information.
Frequently Asked Questions
DAMORA THERAPEUT investment returns
How much would $1,000 invested in DAMORA THERAPEUT be worth today?
Limited historical data is available for DMRA. The stock has been trading since 2026-03-10.
Has DAMORA THERAPEUT outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare DMRA performance over available time periods.
What is DAMORA THERAPEUT's average annual return?
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
